What's impacting the Wesfarmers share price on Thursday?

A change of management of an important business has put Wesfarmers in focus.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Wesfarmers shares are slightly in the green today 
  • There is a new leader of the Australian Pharmaceutical Industries (API) business 
  • Wesfarmers is attracted to the long-term attributes of the healthcare sector 

The Wesfarmers Ltd (ASX: WES) share price is currently in the green amid news that Australian Pharmaceutical Industries (API) has a new boss.

Wesfarmers shares are up around 0.1% and the S&P/ASX 200 Index (ASX: XJO) is also up around 0.1%.

Wesfarmers Health is the new division of the company which will be the home of businesses within the space of health, beauty and wellbeing.

According to reporting by the Australian Financial Review, Wesfarmers Health boss Emily Amos is now in charge of running API after Richard Vincent stepped down.

Vincent has reportedly decided to move into an advisory role, so Wesfarmers Health will still be able to benefit from this.

API was the first move by Wesfarmers into the health sector, but Wesfarmers leader Rob Scott said that it will look at any further acquisitions through a "consumer lens" according to the AFR. Beauty and skincare products, as well as digital health, could be areas of interest.

Over time, this segment could have a growing influence on the Wesfarmers share price.

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls

Image source: Getty Images

What are some of the positives of moving into healthcare?

Wesfarmers is attracted to healthcare because it's "an important, large sector with long-term growth tailwinds". From 2019-2020 to 2060-61, the population aged 65 and over will double to 8.9 million.

The company says that there is increasing demand for health, beauty and wellbeing products and services. Wesfarmers noted that customers are becoming more interested in health and wellness. There is also increased focus on preventative health measures and treatments.

Management believes that 'data and digital' can transform the customer journey in healthcare. There are "opportunities to leverage technology to improve health outcomes".

Wesfarmers stated:

With strong fundamentals and the ability to leverage group capabilities, Wesfarmers Health can deliver superior returns over the long-term.

In terms of the API business, there are three segments. There's the pharmacy distribution segment which is one of only four national full-line pharmaceutical wholesalers. Priceline is another segment, which is a leading network of franchised pharmacies and retail stores. Clear Skincare Clinics has a growing footprint in the fragmented and "high growth" non-surgical aesthetics market. It also has an expanding range of high margin own label products.

Wesfarmers share price snapshot

Over the past month, Wesfarmers shares have risen by around 8%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Excited woman holding out $100 notes, symbolising dividends.
Consumer Staples & Discretionary Shares

2 ASX blue-chip shares offering big dividend yields

These businesses offer significant, reliable dividend income.

Read more »

A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side.
Consumer Staples & Discretionary Shares

A2 Milk shares jump again as China worries start to ease

This infant formula stock is back in flavour.

Read more »

A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side.
Consumer Staples & Discretionary Shares

a2 Milk Company posts double digit FY26 revenue growth despite China supply setback

The company continues to face China supply issues and has outlined plans to regain market share.

Read more »

a man sits alone in his house with a dejected look on his face as he looks at a glass of red wine he is holding in his hand with an open bottle on the table in front of him.
Consumer Staples & Discretionary Shares

This ASX wine stock looked ready to recover. Why did it stumble again?

Investors remain divided between strong long-term fundamentals and near-term uncertainty.

Read more »

A photo of a young couple who are purchasing fruits and vegetables at a market shop.
Consumer Staples & Discretionary Shares

Coles shares dive on ACCC competition blow

Coles' growth plans in Western Australia have been stymied by the ACCC.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Consumer Staples & Discretionary Shares

Wesfarmers shares just had their best month in years. Here's why

Retail resilience and expansion are powering Wesfarmers' impressive comeback.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Earnings Results

Which ASX 200 share is jumping 8% on results day?

This result has gone down well with the market. Here's what you need to know.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Consumer Staples & Discretionary Shares

Bell Potter names 3 Australian shares to buy

One of these shares is being tipped to rise over 50% from current levels.

Read more »